GMED - Globus Medical gets FDA approval for two knee replacement products
2024-07-17 14:52:43 ET
More on Globus Medical
- Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
- Globus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript
- Globus Medical up 11% on guidance boost, Q1 results
- Globus Medical Non-GAAP EPS of $0.72 beats by $0.15, revenue of $606.67M beats by $17.08M
- Seeking Alpha’s Quant Rating on Globus Medical